Teva holder plans $14.4M sale of 367,600 shares

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) is the issuer of ordinary shares for which Bridger Management, LLC, on behalf of Swiftcurrent Master Fund, Ltd., has filed a notice of proposed sale under Rule 144.

Rhea-AI Filing Summary

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) is the issuer of ordinary shares for which Bridger Management, LLC, on behalf of Swiftcurrent Master Fund, Ltd., has filed a notice of proposed sale under Rule 144. The notice covers 367,600 ordinary shares of TEVA to be sold through Apex Clearing Corporation on the NYSE.

The filing states an aggregate market value for the securities to be sold of $14,406,244.00 and an approximate 1,166,292,643 TEVA ordinary shares outstanding. The shares proposed to be sold were originally acquired through open market purchases on May 9, 2018. Roberto Mignone of Bridger is identified as a member of TEVA’s board of directors.

Key Figures

TEVA ordinary shares to be sold: 367,600 shares Aggregate market value of securities to be sold: $14,406,244.00 Approximate TEVA ordinary shares outstanding: 1,166,292,643 shares +2 more

5 metrics

TEVA ordinary shares to be sold 367,600 shares Shares of TEVA covered by the Rule 144 notice

Aggregate market value of securities to be sold $14,406,244.00 Value of the 367,600 TEVA ordinary shares in the notice

Approximate TEVA ordinary shares outstanding 1,166,292,643 shares Approximate ordinary shares outstanding referenced in the notice

Date shares originally acquired May 9, 2018 Acquisition date of the TEVA shares proposed to be sold

Date of Rule 144 notice September 18, 2026 Date on which the Form 144 notice is dated

Key Terms

Rule 144, Ordinary Shares, open market purchases, investment manager, +1 more

5 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Ordinary Shares financial

"The Ordinary Shares reported herein to be sold were originally acquired"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

open market purchases financial

"were originally acquired through open market purchases on May 9, 2018."

Open market purchases are buys of a company’s shares (or other securities) made on public exchanges at prevailing market prices rather than through private deals. For investors this matters because when a company buys back its own stock it reduces the number of shares available, which can boost per-share earnings and often signals management’s confidence; it also affects supply, demand and short-term liquidity much like someone quietly buying up items from a crowded marketplace.

investment manager financial

"Bridger serves as the investment manager of Swiftcurrent Master Fund, Ltd."

board of directors financial

"is a member of the board of directors of the Issuer."

The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for TEVA shareholders?

The notice reports that an investment manager intends to sell 367,600 ordinary shares of TEVA under Rule 144. It is a disclosure of a planned resale by an existing holder, not an issuance of new shares by TEVA.

How many TEVA (TEVA) shares are covered by this Rule 144 notice?

The notice covers 367,600 TEVA ordinary shares. These shares are held for the account of Swiftcurrent Master Fund, Ltd., for which Bridger Management, LLC serves as investment manager, and are proposed to be sold through Apex Clearing Corporation on the NYSE.

What is the aggregate market value of the TEVA shares to be sold?

The Form 144 states an aggregate market value of $14,406,244.00 for the 367,600 TEVA ordinary shares covered by the notice. This figure reflects the value used for the Rule 144 disclosure at the time of the filing.

How many TEVA shares were outstanding according to this filing?

The filing reports an approximate 1,166,292,643 TEVA ordinary shares outstanding. This figure provides context for the size of the 367,600-share proposed sale relative to TEVA’s total ordinary shares.

When and how were the TEVA shares originally acquired?

The filing states that the TEVA ordinary shares proposed to be sold were originally acquired through open market purchases on May 9, 2018. This acquisition date and method are disclosed in the remarks section of the notice.

Who is the person associated with the selling holder in this TEVA filing?

The remarks explain that Bridger Management, LLC is the investment manager of Swiftcurrent Master Fund, Ltd., which holds the TEVA shares. They also note that Roberto Mignone, Bridger’s Founder and Managing Partner, is a member of TEVA’s board of directors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/18/2026 - 05:00 PM Accepted by SEC EDGAR 09/18/2026 - 05:00 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001166309
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TEVA PHARMACEUTICAL INDUSTRIES LTD
SEC File Number	001-16174
Address of Issuer	124 Dvora HaNevi'a St Tel Aviv ISRAEL 6944020
Phone	973-914-8213
Name of Person for Whose Account the Securities are To Be Sold	Bridger Management, LLC (1)
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Shareholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Apex Clearing Corporation 350 N St. Paul, Suite 300 Dallas TX 75201	367600	14406244.00	1166292643	09/18/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	05/09/2018	See Remark 2	See Remark 2			367600	05/09/2018	See Remark 2

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	(1) Bridger Management, LLC ("Bridger") serves as the investment manager of Swiftcurrent Master Fund, Ltd., which holds the Ordinary Shares covered by this Form 144. Roberto Mignone, Founder and Managing Partner of Bridger, is a member of the board of directors of the Issuer. (2) The Ordinary Shares reported herein to be sold were originally acquired through open market purchases on May 9, 2018.
Date of Notice	09/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Bridger Management, LLC, By: /s/ Matthew P. Truax, Chief Operating Officer, General Counsel and Chief Compliance Officer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)